Functional Precision Medicine: Putting Drugs on Patient Cancer Cells and Seeing What Happens

For too long, assays exposing patient tumor cells to drugs to identify active therapies have been dismissed as ineffective. In this issue of Cancer Discovery, two groups independently demonstrate clinical utility of such functional precision medicine assays in hematologic malignancies.

Automated summary

The article discusses the clinical utility of functional precision medicine assays in hematologic malignancies, which has been previously dismissed as ineffective.